Literature DB >> 2453686

Administration of immune globulin associated with aseptic meningitis.

E Kato, S Shindo, Y Eto, N Hashimoto, M Yamamoto, Y Sakata, Y Hiyoshi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2453686

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.

Authors:  M Casteels-Van Daele; L Wijndaele; P Brock; M Kruger; P Gillis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

2.  Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.

Authors:  J D Watson; J Gibson; D E Joshua; H Kronenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-03       Impact factor: 10.154

Review 3.  Drug-induced aseptic meningitis: diagnosis and management.

Authors:  S Jolles; W A Sewell; C Leighton
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 4.  Recognition and management of myositis.

Authors:  P Cherin
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

5.  Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis.

Authors:  Z Meiner; T Ben-Hur; Y River; A Reches
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

6.  Aseptic meningitis: a frequent side-effect of intravenous immunoglobulin?

Authors:  R Preminger-Shapiro; M Nussinovitch; G Soen; I Varsano
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

7.  Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura.

Authors:  M Mitterer; N Pescosta; W Vogetseder; M Mair; P Coser
Journal:  Ann Hematol       Date:  1993-09       Impact factor: 3.673

Review 8.  Side-effects of intravenous immune globulins.

Authors:  C Duhem; M A Dicato; F Ries
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 9.  Adverse effects of intravenous immunoglobulin.

Authors:  S A Misbah; H M Chapel
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

10.  Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease.

Authors:  Yasushi Kemmotsu; Tomotaka Nakayama; Hiroyuki Matsuura; Tsutomu Saji
Journal:  Pediatr Rheumatol Online J       Date:  2011-09-14       Impact factor: 3.054
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.